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Abstract
Background: A study including 166 subjects was performed to investigate the frequency and persistence over a 6-
month interval of concurrent oral and anal Human Papillomavirus (HPV) infections in Human Immunodeficiency
Virus (HIV)-infected men who have sex with men (MSM).
Methods: Patients with no previously documented HPV-related anogenital lesion/disease were recruited to
participate in a longitudinal study. Polymerase chain reaction (PCR) was performed to detect HPV from oral and
anal swabs and to detect Human Herpes Virus 8 (HHV-8) DNA in saliva on 2 separate specimen series, one
collected at baseline and the other collected 6 months later. A multivariate logistic analysis was performed using
anal HPV infection as the dependent variable versus a set of covariates: age, HIV plasma viral load, CD4+ count,
hepatitis B virus (HBV) serology, hepatitis C virus (HCV) serology, syphilis serology and HHV-8 viral shedding. A
stepwise elimination of covariates with a p-value > 0.1 was performed.
Results: The overall prevalence of HPV did not vary significantly between the baseline and the follow-up, either in
the oral (20.1 and 21.3%, respectively) or the anal specimens (88.6 and 86.3%). The prevalence of high-risk (HR)
genotypes among the HPV-positive specimens was similar in the oral and anal infections (mean values 24.3% and
20.9%). Among 68 patients with either a HR, low-risk (LR) or undetermined genotype at baseline, 75% had
persistent HPV and the persistence rates were 71.4% in HR infections and 76.7% in LR infections. There was a lack
of genotype concordance between oral and anal HPV samples. The prevalence of HR HPV in anus appeared to be
higher in the younger patients, peaking (> 25%) in the 43-50 years age group. A decrease of the high level of anal
prevalence of all genotypes of HPV in the patients > 50 years was evident. HHV-8 oral shedding was positively
related to HPV anal infection (p = 0.0046). A significant correlation was found between the persistence of HHV-8
shedding and HIV viral load by logistic bivariate analysis (Odds Ratio of HHV-8 persistence for 1-log increase of HIV
viral load = 1.725 ± 0.397, p = 0.018).
Conclusions: A high prevalence of HPV infection was found in our cohort of HIV-infected MSM, with a negative
correlation between anal HPV infection and CD4 cell count.
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Human papillomavirus infections are among the most
common sexually transmitted infections worldwide,
representing a significant health problem due to their
high prevalence and transmissibility. HPV is a leading
cause of anogenital malignancies. The incidence of anal
cancer is particularly high among women with a history
of cervical dysplasia and cervical cancer, HIV-positive
individuals, Men who have sex with Men (MSM) and
transplant recipients [1]. Anal cancer is increasingly
recognised as an immunodeficiency-related cancer, and
there is strong evidence that the incidence of anal can-
cer is stable or increasing in homosexual men and peo-
ple with HIV infection, even in the highly active
antiretroviral therapy (HAART) era [2-6].
Several studies have found high rates of anal HPV
infections in HIV-infected patients [6-9]. Prevalence
estimates vary according to the diagnostic methods and
populations examined. MSM living with HIV are parti-
cularly susceptible to HPV infection, often involving
multiple strains of HPV.
Recent molecular and epidemiological studies have
demonstrated a role for HPV in the aetiology of oro-
pharyngeal cancers [10,11]. High-risk (HR) HPV, predo-
minantly type 16, has been consistently detected in a
distinct subset of these cancers [10]. Despite these
important observations, little is known about the epide-
miology of oral HPV infection. Initial studies indicate
that oral HPV infection, analogous to cervical infection,
is associated with sexual behaviour and immunosuppres-
sion [12,13]. However, it is unclear to what extent data
on cervical HPV infection can be extrapolated to oral
HPV infection. Likewise, data on the spread of HPV
infection to the various body parts implicated in sexual
practices are limited.
HPV infection is associated with oral squamous cell
carcinoma (OSCC). Although the incidence of HPV-
unrelated OSCC associated with tobacco and alcohol
use has declined over recent decades, OSCC related to
HPV has significantly increased, particularly among
white men and younger individuals [14]. This may be a
result of changes in sexual behaviours. Given the inci-
dence ratio of 2.32 for OSCC in HIV-infected persons,
particular attention should be paid to this oral cancer in
the setting of HIV infection, especially in HIV-positive
MSM [3].
The few available studies analysing concurrent or
sequential oral and anogenital HPV infections have used
the similar study populations: high-risk sex workers,
women with a history of cervical HPV infection, and
HIV-positive women [15-18]. Several aspects of the rela-
tionship of oral HPV infection to anal HPV infection
remain poorly described. These include differences in
HPV prevalence and HPV type distribution by anatomic
site, the prevalence of concomitant oral and anal infec-
tions, and whether concomitant infections are type con-
cordant. Oral sex is a common practice among MSM
and may lead to the transmission of various STDs
[19-21].
This study was designed to investigate the frequency
and persistence over a six-month interval of concurrent
oral and anal HPV infection in a cohort of HIV-infected
MSM and to investigate correlations between these
infections and virological and immunological status
related to HIV and other infections, including HHV-8,
HBV, HCV, and syphilis.
Methods
From December 2007 to June 2009, HIV-positive MSM
attending the Infectious Disease Unit of the Padua Uni-
versity Hospital as outpatients were recruited to partici-
pate in a longitudinal study of HPV infection. Eligibility
criteria included being > 18 years of age, able to provide
informed consent and having no history of or current
symptomatic HPV-related anogenital lesions/diseases.
Each subject underwent clinical evaluation and sample
collection on two different occasions separated by 6
months. HPV was assayed from oral and anal swabs.
All virologic and serologic tests were performed as a
part of the diagnostic procedures performed periodically
on these HIV patients. All subjects enrolled gave their
informed consent to all procedures and to the use of
their data for scientific evaluation and publication in a
blinded form. The local government in the form of the
Veneto Regional Health Authority approved this study
and provided funds. This study was conducted in accor-
dance with the Helsinki Declaration and with local
legislation.
At each visit, a PBS-moistened anal Dacron swab was
inserted 3 cm into the anal canal and then used to
scrape along the anal walls by rotating three times
clockwise and three times anticlockwise. Another swab
was used for oral sampling; oral samples were obtained
by vigorous scraping of the walls of the oropharyngeal
cavity by rotating two times clockwise and two times
anticlockwise. The swab samples were then agitated in
1.5 mL of 1 × PBS (Phosphate-Buffered Saline). Each
sample was kept at 4°C and processed within four
hours. After centrifugation at 13,000 g for 15 min at 22°
C, the supernatant was discarded, the cell pellet was
dried and resuspended in 300 ul of 20 mmol/L Tris buf-
fer (pH 8.3) and then frozen at -80°C. Total DNA was
extracted using the QIAamp DNA Mini Kit (Qiagen,
GmbH, Hilden, Germany), and DNA extracted from the
samples was first tested with primers PC04 and GH20,
targeting a 268 bp fragment of beta-globin. Samples
negative for beta-globin were not considered for further
analysis. DNA was purified using ExoSAP-IT (USB
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DNA was investigated by PCR using MY09/MY11 pri-
mers and, if HPV DNA was not detected, GP5+/GP6+
primers [22-24]. Nested PCR was not used. To identify
the HPV genotype, amplicons that were detected by
agarose gel electrophoresis were subsequently submitted
to sequencing by using the BigDye1 Terminator v3.1
Cycle Sequencing Kit on a 3100 Genetic Analyser
(Applied Biosystems, Foster C i t y ,C A ) .A f t e ra l i g n m e n t
using the SeqScape v2.5 software (Applied Biosystems),
sequences were analysed in GenBank by using the NCBI
BLAST tool. The risk level of each genotype was classi-
fied according to oncogenic properties in the cervix [25].
Thus, genotypes 10, 32, 34, 38, 43, 85, 86, 90, and 97
were considered of undefined oncogenic risk, 6, 11, 26,
40, 42, 53, 54, 55, 61, 62, 64, 66, 67, 69, 70, 71, 72, 73, 81
82, 83, 84, IS39 and CP6108 of low risk (LR), 16, 18, 31,
33, 35, 39, 45, 51, 52, 56, 58, 59, 68 and 73 of high risk.
HHV-8 DNA detection by PCR was also performed on
the saliva from all patients. Briefly, DNA extraction and
purification from the saliva samples (500 ul, processed
as plasma samples) was performed using the QIAmp
Blood kit (Qiagen, Inc., Chatsworth, CA). The detection
of HHV-8 DNA in samples was performed using the
real-time polymerase chain reaction (RT-PCR) using
TaqMan probes (Applied Biosystems, Foster City, CA)
of open reading frame 26 (ORF26) as previously
described [26]. The nucleotide sequence targeted by the
primers and probes is highly conserved among the three
major subgroups of HHV-8 [27]. During all DNA
extractions and purifications, precautions were taken to
reduce the risk of false-positive results.
HIV plasma viral load (copies/ml) was evaluated using
the Roche Cobas AmpliPrep-Cobas TaqMan HIV-1
assay, version 1 (F. Hoffmann-La Roche, Diagnostics
Division, Basel, Switzerland).
Data collection and statistical analysis
Data collected at study entry included age in years,
whether the patient was receiving antiretroviral treat-
ment, CD4 lymphocyte count (cells/μl), serology for T.
pallidum infection, and HBV and HCV serology.
The PCR assays for HPV in oral and anal swabs and
for HHV-8 in saliva were performed on 2 separate spe-
cimens, one collected at baseline and a second collected
after a 6-month interval. The age, HIV viral load in
plasma and CD4 count were considered as quantitative
(continuous) variables, while the remainder of the vari-
ables were binary. The detection of HPV genomes was
binary and positives were supplemented by genotype
identification. The serology for syphilis included a non-
treponemal test (Venereal Disease Research Laboratory
(VDRL)), a treponemal test (Treponema hemagglutina-
tion test (TPHA)), and an ELISA screening test.
A multivariate logistic analysis was performed using
the presence of anal HPV infection as a dependent vari-
able versus a set of covariates including: age, HIV viral
l o a d ,C D 4c e l lc o u n t ,H B Vs e r o l o g y ,H C Vs e r o l o g y ,
syphilis serology and HHV-8 viral shedding. The study
participants’ ages was broken into 4 groups (< 35, 35-42,
43-50, and > 50 years). A stepwise elimination of covari-
ates with a p-value > 0.1 was adopted.
Results
At o t a lo f1 6 6m e nw e r ee n r o l l e di nt h i ss t u d y .T h e
characteristics of the study population are listed in
Table 1. Paired concurrent anal and oral swabs were
collected from all 166 of the patients at baseline. There
were 49 withdrawals from the study, meaning that speci-
mens at the 6 month follow-up were available from only
117 patients. Moreover, 41 oral swabs (thirty-two at
baseline: 19%, nine at follow-up: 7.7%) were not able to
b ee v a l u a t e db yP C Rd u et oi n a d e q u a t es a m p l i n g
revealed by the inability to detect beta-globin in the
DNA sample. All anal swabs were adequate for sam-
pling. Therefore, 283 anal swabs and 242 oral swabs
were available for analysis. The HPV detection in oral
and anal swabs is indicated in Table 2. The overall
Table 1 Baseline characteristics of the study population
Age
mean ± SD 43.8 (± 12.31)
median (range) 42 (21-80)
CD4 count
mean (± SD) 563 (± 262)
median (range) 515 (0-1390)
HIV viral copies/ml
mean ± SD 68.356 (± 250.712)
median (range) 372 (< 20-2,139.627)
viral load < 20 copies/ml: no. pts. (%) 38 (22.9)
Antiretroviral treatment: no. pts. (%)
Yes 87 (63)
No 51 (37)
No data 28 (16.8%)
HHV-8 DNA shedding in saliva: no. pts. (%)
Pos./neg. 36/105 (25.5/74.5%)
No data 25 (15)
HBV serology: no. pts. (%)
Pos./neg. 46/94 (32.8/67.2)
No data 26 (15.6)
HCV serology no. pts. (%)
Pos./neg. 4/129 (3/97)
No data 33 (19.9)
Any serological syphilis positive test: no. pts. (%)
Pos./neg. 56/83 (40.3/59.7)
no data 27 (16.2)
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the baseline and follow-up time points and was 20.1 vs.
21.3% in oral specimens ((p-value = 0.8266) and 88.6 vs.
86.3% in anal specimens (p-value = 0.5748). The preva-
lence of HR genotypes among HPV-positive specimens
was similar in oral and anal infections (mean values
24.3% and 20.9%, p-value = 0.6417). Among the 68
patients with HR, LR, or undetermined genotypes at the
baseline in their anus who provided two consecutive
anal samples, 75% (51/68) had persistent HPV six
months after enrolment. Persistence rates of 71.4% (10/
14) in patients with high-risk infections and 76.7% (33/
43) in patients with low-risk infections were found.
Rates of persistence of HPV according to the level of
risk associated with the HPV genotype are shown in
Table 3. The HPV genotype distribution in oral and
anal swabs is depicted in Figure 1. There was no geno-
type concordance between oral and anal HPV types,
with the exception of non-typeable strains in 3 paired
oral and anal swabs (in a single patient at baseline and
in two patients at follow-up). Genotype identification
was not performed when multiple co-infecting HPV
strains were obtained (Table 2).
The prevalence of HPV anal infection and the HR
genotype prevalence in various age groups are reported
in Figure 2. These data suggest the existence a high anal
prevalence of all HPV genotypes, and a decrease of this
prevalence in the > 50 years age group. Likewise, the
HR genotype prevalence is higher in the younger age
groups, peaking (> 25%) in the 43-50 years age group
and then declining. The changes of high-risk genotypes
associated with age were not statistically significant but
were close to the cut-off level [c
2 (3 d.o.f.) = 7.63, p-
value = 0.054].
A bivariate pairwise correlation analysis was per-
formed to explore relationships between the main vari-
ables. A positive correlation between positive results
from any syphilis diagnostic test and the presence of HR
HPV genotypes in anal swabs was found, and this corre-
lation was statistically significant (p = 0.0346). Positive
syphilis tests were positively related to age (p = 0.0169)
and positive HCV serology (p = 0.016). Anal swab HPV
detection at either time-point was positively related to
higher HIV plasma viral load (p = 0.0184) and negatively
to antiretroviral therapy (p = 0.0419).
When the logistic multivariate analysis was performed,
after stepwise elimination of the covariates with a p-
value > 0.1, only two significant covariates, “age” and
“CD4”, were retained in the final model (Table 4, and
Figure 3). The relationship between anal HPV infection
and age was negative (decreasing) as was the relation-
ship with anal HPV infection and CD4 lymphocyte
count.
HHV-8 oral shedding was positively related to HPV
i n f e c t i o ni na n a la r e a( c
2 (1 d.o.f.) = 8.03, p-value =
0.0046). Moreover, a significant correlation was found
between the persistence of HHV-8 shedding and HIV
log10 (viral load) by logistic bivariate analysis (OR of
HHV-8 persistence for 1 log increase of HIV viral load
= 1.725 ± 0.397, p-value = 0.018).
Discussion
T h ef e ws t u d i e st h a th a v ea n a l y s e dc o n c u r r e n to r
sequential oral and anogenital HPV infections have
examined similar study populations: high-risk sex work-
ers, women with a history of cervical HPV infection,
and HIV-positive women [15-18]. In the present
Table 2 HPV detection in oral and anal swabs of HIV-positive homosexual men
Oral swab (baseline) Oral swab (follow-up) Anal swab (baseline) Anal swab (follow-up)
Positives 27 20.1% 23 21.3% 147 88.6% 101 86.3%
Genotyped 18 66.7% 19 82.6% 112 76.2% 70 69.3%
High-Risk 2 11.1% 7 36.8% 27 24.1% 11 15.7%
Low-risk 12 66.6% 5 26.3% 65 58% 49 70%
Negatives 107 79.9% 85 78.7% 19 11.4% 16 13.7%
Total evaluable specimens 134 108 166 117
Invalid Samples* 32 19% 9 7.7% 0 0
Rates of positive and negative specimens calculated based on total evaluable specimens. Rate of high-risk type calculated based on genotyped strains.
*absence of beta-globin in the sample
Table 3 Persistence of HPV in the anal area according to
the risk level of the viral genotype
Risk level in 1
st anal sample Persistence
no yes total %
LR 10 33 43 76.7%
undetermined 3 8 11 72.7%
HR 4 10 14 71.4%
Total 17 51 68 75.0%
HPV genotypes are grouped by oncogenic risk or are indicated as negative
HPV samples. LR: low-risk; undetermined: undetermined-risk; possible HR:
possible high-risk; HR: high-risk. Table cells contain counts, i.e., numbers of
patients. The rate (percentage) of persistence is indicated by oncogenic risk.
No difference was detected among the various rates (Pearson’s Chi
2 (3) =
0.1397, P-value = 0.987).
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MSM, we have found a high prevalence of HPV infec-
tion in the anal area, both at initial screening (88.6%)
and follow-up (86.3%). These findings are consistent
with those of two other longitudinal studies conducted
in HIV MSM, suggesting that HIV infection not only
increases susceptibility to persistent HPV but also
increases the risk of acquisition of new HPV infections
Figure 1 HPV genotype distribution of all oral and anal infections detected among paired oral and anal swabs. A: HPV genotype
distribution at baseline; B: HPV genotype distribution in subsequent specimens (6 months after study entry). n.t.: non-typeable HPV strains. The
genotype is indicated on the abscissa. Genotypes 10, 32, 34, 38, 90, (anal swabs) and 10, 97 (oral swabs) are of undefined oncogenic risk;
genotypes 6, 11, 40, 53, 54, 61, 62, 66, 70, 71, 72, 81, 83, 84 (anal swabs) and 6, 66, 81 (oral swabs) are low-risk; genotypes 16, 18, 33, 35, 58 (anal
swabs) and 16, 18, 33, 35, 56, 58, 73 (oral swabs) are high-risk.
Figure 2 Prevalence of all HPV genotypes in the anal area and
of high-risk genotypes in four age groups. Blue: high-risk HPV
genotypes; red: all HPV genotypes. The percentages refer to the
numbers of patients included in the relevant age group: 33 (< 35
years), 41 (35-42 years), 31 (43-50 years), and 34 (> 50 years). The
age group delimiters are the 25th, 50th, 75th percentiles.
Table 4 Multivariable logistic analysis
anal_HPV Coef. Std. Err. Z p-value 95% Conf. Interval
Age -0.07322 0.024486 -2.99 0.003 -0.12121 -0.02523
CD4 -0.00204 0.001008 -2.02 0.043 -0.00402 -6.5E-05
Intercept 6.739866 1.527239 4.41 0.000 3.746532 9.733199
Dependent variable: anal_hpv. The number of observations used by the
model was 136. Based on LR Chi
2 (2) = 12.62, the model was significant as
quantified by a p-value = 0.0018.
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Our overall HPV anal prevalence data are consistent
with those of earlier studies conducted in HIV-infected
populations [7,29-31]. However, compared to previous
studies, we have found a lower rate of HR types and a
higher prevalence of LR or possible HR types. This
observation is not surprising because the prevalence of
infection with HR HPV types may differ substantially by
geographic location [32]. When analysing specific HPV
types, we found that the low-risk HPV-6 type was the
most common HPV type (13% of specimens at screen-
ing and 16% at follow-up), followed by HPV-16 (13 and
7%), HPV-11 (12 and 3%), HPV-66 (11 and 7%) and
HPV-61 (12 and 5%). A higher prevalence of HR types
has been found in anal samples from HIV-infected
patients in previous studies, with rates of up to 70%
observed [7]. Conversely, low-risk genotypes have been
found in higher proportions in heterosexual men with
no other sexually transmitted diseases and in a small
dataset of HIV-infected patients [8,33]. A number of
subjects had anal infections with an HPV strain with an
undetermined risk level (17.8% at baseline and 14.2% at
follow up among genotyped strains).
In a more recent report on HIV-infected MSM [9],
most patients (90.9%) were infected with multiple HPV
types in the anal canal, with a median number of 5
HPV types per sample (range: 0-18). The median num-
ber of HR HPV types was 5 per sample (range: 0-12).
The different methods used for HPV typing by the
authors of these studies makes it difficult to compare
their results with the results of the present study. These
authors obtained genotypes using the reverse line-blot
detection system [34] that is able to identify 36 genital
HPV types; samples that were not positive for any of
these types were considered HPV negative. This method
enabled the authors to demonstrate the presence of co-
infection. We chose a population sequencing method,
which is less able to demonstrate viral co-infections, to
be able to find rare genotypes. However, minority geno-
types are easily overlooked. Nevertheless, in our study,
multiple HPV infections, which can be identified some-
times during editing of the electropherograms as multi-
ple sequences, appear to occur less frequently than in
the HIPVIRG study.
Current data on the spread of HPV infection to var-
ious body parts implicated in sexual practices in both
MSM and heterosexual individuals are limited. Oral sex
behaviours have been associated with oral HPV infection
and the transmission of other viral infections such as
HSV [13,35]. Moreover, sexual behaviours are associated
with a risk of cancer at the head and neck subsites that
have previously been associated with HPV infection
[36]. In the present study, the prevalence of HPV in oral
samples was 20.1% at screening and 21.3% at follow-up.
There are limited data in the literature concerning the
relationship between oral and cervical HPV infection, an
emerging area of research given the potentially increased
risk of HPV-associated oropharyngeal cancers in HIV-
positive individuals [37]. In a study of 30 HIV-positive
women from South Africa who were naïve to ART and
had a CD4 count of less than 300, oral HPV DNA was
detected in 20% of oral specimens from the women and
in 97% of the cervical specimens from the same women
[38]. A limited correlation between oral HPV types and
those identified in the cervical mucosa was found. In a
larger study of ART-experienced women from the U.S.
A., HIV-positive women were more likely to have
detectable oral HPV infection than HIV-negative
women (33 vs. 15%, p = 0.016) [39]. However, the pre-
valence of oral HPV infection over six months was sig-
nificantly less than for cervical infection (p < 0.0001).
These data suggest that while oral HPV infection is
more common among HIV-positive women compared
with HIV-negative women, the incidence and natural
history of HPV infection at these two mucosal sites are
not highly correlated. A similar relationship was noted
in the past between cervical HPV infection and anal
HPV infection in HIV-positive women [40]; while anal
infection was more common than cervical infection, the
HPV types detected at the two sites were different in
the majority of the women.
There are fewer studies on HPV prevalence in oral
specimens from men and these studies are difficult to
compare. HPV infection was detected in 4.8% of 332
control patients from an outpatient clinic and in 2.9% of
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sex and open-mouthed kissing were associated with the
development of oral HPV infection. Oral HPV infection
is strongly associated with oropharyngeal cancer among
subjects with or without the established risk factors of
tobacco and alcohol use [42]. Data from another study
show that HPV is detectable in clinically normal oral
mucosa in approximately one third of the general popu-
lation, while the detection rate observed in HIV-positive
individuals is up to 60% [43]. We found the prevalence
of HPV in oral specimens of HIV-infected MSM to be
around 20% and we did not find genotype concordance
between oral and anal HPV genotypes. Taking into
account potential bias due to the lack of information
from the 14.5% inadequate samples, this observation is
higher than that seen in other studies (5.5% reported by
Fakhry in 2006), and our data are similar to those
reported by Palesky and colleagues in HIV-positive
women [40].
Our findings show that the prevalence of HR HPV
genotypes was highest in the 43-50 year old age group,
where it was over 25%. The persistence of HR genotypes
(71.4%) did not exceed the persistence of low-risk geno-
types (76.7%), although further surveillance of this
cohort will be necessary to understand of the determi-
nants of HPV persistence. The presence of an HPV-
positive anal swab was negatively related to age, CD4
count and antiretroviral treatment, and positively related
to HIV viral load. The negative correlation between anal
HPV infection and CD4 count, albeit expected, warrants
further study and corresponds with the positive correla-
tion with HIV plasma viral load. These observations
support a role for HIV viral replication and immunode-
ficiency in affecting susceptibility to infection with all
genotypes of HPV infection in the anal area or the abil-
ity to clear HPV.
The relationship between anal HPV infection and age
was negative (decreasing) both by linear regression
(using age as a dependent variable) and by logistic
regression. However, we interpret this finding to be
somewhat artifactual, as the age-related prevalence of all
HPV genotypes shows a plateau followed by a decline in
the group older than 50 years, whereas the high-risk
HPV genotype infections show a peak in the 43-50 years
age group, in partial agreement with Nyitray [44]. More-
over, two subpopulations were detected: a larger and
younger population with a lower antiretroviral treatment
rate, less control of HIV replication, lower CD4 levels,
and a higher prevalence of anal HPV infection, including
high-risk genotypes, and a smaller, older subpopulation
with opposite features.
The correlation between HPV infection and T. palli-
dum infection was close to the significance level and
became significant when the possible high-risk
genotypes 53 and 66 were included in the analysis.
Syphilis (active, latent or treated) was positively related
to age, HCV infection, and, unexpectedly, lower HIV
plasma viral load and higher CD4 count. The latter two
correlations are probably explained by the characteristics
of the older HIV patients, as the older patients were
more often receiving ART and as a consequence, they
had lower viral loads and higher CD4 cell counts. The
association between syphilis and HCV infection is some-
what unexpected, since recent data suggests that permu-
cosal HCV transmission mig h tr e s u l tf r o mh i g h - r i s k
sexual and non-injecting drug use behaviours among
MSM, raising the question of the importance of sexual
transmission of HCV [45].
HHV-8 oral shedding was positively related to HPV
infection in anal area: HPV infection rates were 63.6%
in the HHV-8-positive and 30.0% in HHV-8-negative
group. It has been demonstrated that the risk of HHV-8
infection among men in the United States and Western
Europe is closely related to the number of male sexual
partners, and in these populations sexual intercourse is
the major mode of HHV-8 transmission [46,47]. A sig-
nificant correlation was also found between the persis-
tence of HHV-8 shedding and HIV viral load. We have
previously demonstrated that HHV-8 viral load persists
for up to 6 months in the majority of patients with con-
current HIV viral load, whereas all of the patients on
ART with undetectable HIV viral load cleared HHV-8
from the plasma after a mean period of 12 months after
the first positive blood specimen [48].
Some limitations of our study should be addressed.
Our data lack information regarding a number of sub-
jects and the robustness of our correlations should be
confirmed with further observations. HPV genotyping
was performed using a population sequencing method
that does not allow us to fully characterise co-infections
and to correctly trace all genotypes found during the
double sampling. Nevertheless, this method allowed us
to demonstrate a high prevalence of infection by unde-
termined-risk HPV types.
In conclusion, the negative relation between anal HPV
infection and CD4 count detected by this multivariate
logistic procedure, albeit expected, deserves interest and
is in agreement with the positive correlation with HIV
plasma viral load found using a bivariate analysis.
Conclusions
These observations support a role for the HIV viral
replication rate and immunodeficiency in affecting
patient susceptibility to infection with all genotypes of
HPV infection in the anal area and with HPV clearance.
Moreover, two subpopulations were detected: a larger
and younger subpopulation with a lower antiretroviral
treatment rate, less control of HIV replication, lower
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Page 7 of 9CD4 counts, and higher prevalence of anal HPV infec-
tion including high-risk genotypes, and a smaller, older
subpopulation with opposite features. The increasing
incidence of anal cancer in the HIV-positive population
make new strategies addressing HPV infection monitor-
ing, control and prevention necessary; further studies
addressing vaccine efficacy, HPV viral load and the role
of undetermined risk variants are needed.
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